Oncology

Most Oncology Brands Lose Before Launch Day — New ZoomRx Analysis of 40+

Veracyte Announces First Quarter 2026 Financial Results

Exelixis Announces First Quarter 2026 Financial Results and Provides Corpor

Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® L

ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD

Paige Launches New System-Wide AI Application for the Gastrointestinal Trac

BostonGene Named a Fierce Life Sciences Innovation Awards Winner in the AI

Crown Bioscience Appoints John Gu as Chief Executive Officer

ClearNote Health’s Avantect® Pancreatic Cancer Test Now Available to Hea

Guardant Health Receives ADLT Status From CMS for Shield Blood Test

Ionis and Ono announce global license agreement for sapablursen in polycyth

Pramana and ARUP Laboratories Partner to Digitize Pathology Slides and Deve

ZAP Surgical Unveils the ZAP-Axon® Radiosurgery Planning System

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companio

Schrödinger Expands Board of Directors with Appointment of Bridget van Kra

bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Co

VSee Issues Shareholder Letter Highlighting 2024 Achievements and Strong Gr

Butterfly Network to Participate at Oppenheimer 35th Annual Healthcare MedT

Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Milli

Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(